Oncorus ONCR
$ 0.12
-8.54%
Quarterly report 2023-Q1
added 05-22-2023
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Mitchell H. Finer |
Employees in the company |
51 |
Shares |
25.9 K |
Market Cap[1] |
$ 3.19 M |
EBITDA (LTM) |
$ -78.6 M |
P/E (LTM) |
-0.1 |
P/S (LTM) |
- |
EPS (LTM) |
-3.28 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.